Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-002458
Filing Date
2020-03-12
Accepted
2020-03-11 21:33:06
Documents
101
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K idra-20191231x10k.htm 10-K 4452319
2 EX-4.11 idra-20191231ex41189d232.htm EX-4.11 116164
3 EX-4.12 idra-20191231ex412162116.htm EX-4.12 46076
4 EX-4.13 idra-20191231ex41393fc46.htm EX-4.13 467945
5 EX-4.14 idra-20191231ex4142100ae.htm EX-4.14 20317
6 EX-10.42 idra-20191231ex104228257.htm EX-10.42 49181
7 EX-23.1 idra-20191231ex231ae13dc.htm EX-23.1 33133
8 EX-31.1 idra-20191231ex311b541e8.htm EX-31.1 24937
9 EX-31.2 idra-20191231ex312ebc173.htm EX-31.2 25862
10 EX-32.1 idra-20191231ex3216d157e.htm EX-32.1 8967
11 EX-32.2 idra-20191231ex322f3f75b.htm EX-32.2 9118
12 GRAPHIC idra20191231x10k001.jpg GRAPHIC 12769
13 GRAPHIC idra20191231x10k002.jpg GRAPHIC 6556
14 GRAPHIC idra20191231x10k003.jpg GRAPHIC 7231
15 GRAPHIC idra20191231x10k004.jpg GRAPHIC 6415
16 GRAPHIC idra20191231x10k005.jpg GRAPHIC 6047
  Complete submission text file 0001558370-20-002458.txt   12635356

Data Files

Seq Description Document Type Size
17 EX-101.INS idra-20191231.xml EX-101.INS 2157525
18 EX-101.SCH idra-20191231.xsd EX-101.SCH 77231
19 EX-101.CAL idra-20191231_cal.xml EX-101.CAL 59368
20 EX-101.DEF idra-20191231_def.xml EX-101.DEF 297242
21 EX-101.LAB idra-20191231_lab.xml EX-101.LAB 576356
22 EX-101.PRE idra-20191231_pre.xml EX-101.PRE 504454
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31918 | Film No.: 20707028
SIC: 2836 Biological Products, (No Diagnostic Substances)